Disease course and treatment patterns in progressive supranuclear palsy: A real-world study

The genetic and clinico‐pathological profile of early‐onset progressive supranuclear palsy

(2019) Edwin Jabbari et al.   MOVEMENT DISORDERS

Descriptive epidemiology of parkinsonism in the Canton of Geneva, Switzerland

(2018) Vanessa Fleury et al.   PARKINSONISM & RELATED DISORDERS

Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches

(2017) Adam L Boxer et al.   LANCET NEUROLOGY

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

(2017) Günter U. Höglinger et al.   MOVEMENT DISORDERS

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options

(2016) Ruth Lamb et al.   Current Treatment Options in Neurology

Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes

(2016) Ian T.S. Coyle-Gilchrist et al.   NEUROLOGY

Tremor in progressive supranuclear palsy

(2016) Shinsuke Fujioka et al.   PARKINSONISM & RELATED DISORDERS

Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme

(2016) S M Babineaux et al.   BMJ Open

Prevalence of progressive supranuclear palsy in Yonago: change throughout a decade

(2016) Hiroshi Takigawa et al.   Brain and Behavior

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015

(2016) Victoria Higgins et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Progressive supranuclear palsy: progression and survival

(2015) Julieta E. Arena et al.   JOURNAL OF NEUROLOGY

Rate of decline in progressive supranuclear palsy

(2014) Irene Litvan et al.   MOVEMENT DISORDERS

Progressive Supranuclear Palsy

(2014) Lawrence Golbe   SEMINARS IN NEUROLOGY

Fifty years of progressive supranuclear palsy

(2013) C. Colosimo et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism

(2013) Rodolfo Savica et al.   JAMA Neurology

Amantadine for Freezing of Gait in Patients With Parkinson Disease

(2012) Roneil Malkani et al.   CLINICAL NEUROPHARMACOLOGY

Treatment Options for Tauopathies

(2012) Tarik Karakaya et al.   Current Treatment Options in Neurology

External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?

(2012) C. Saunders et al.   DIABETIC MEDICINE

Neuropathology of variants of progressive supranuclear palsy

(2010) Dennis W Dickson et al.   CURRENT OPINION IN NEUROLOGY

A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy

(2010) Anette Schrag et al.   MOVEMENT DISORDERS

Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges

(2009) David R Williams et al.   LANCET NEUROLOGY

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy

(2008) S. S. O'Sullivan et al.   BRAIN

Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand

(2008) P. Anderson et al.   CURRENT MEDICAL RESEARCH AND OPINION

Early diagnosis of progressive supranuclear palsy: Bucking the odds

(2008) L. I. Golbe   NEUROLOGY